← Back to Clinical Trials
Recruiting NCT07214233

NCT07214233 Youth Empowerment and Safety Intervention

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07214233
Status Recruiting
Phase
Sponsor Case Western Reserve University
Condition Suicide
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2026-02-23
Primary Completion 2027-11-30

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
Treatment as UsualPeer Support Services (PSS)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2026-02-23 with a primary completion date of 2027-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This clinical trial will implement and evaluate the feasibility, acceptability, and initial impact of Peer Support Specialist (PSS) services for public system-involved sexual and gender minority (lesbian, gay, bisexual, queer and/or transgender) youth (SGMY) at risk of suicide.

Eligibility Criteria

Child Inclusion Criteria: * 12-17 years of age * Self-identify as a sexual or gender minority (SGM) * Involved in one or more system: juvenile justice, child welfare, and/or community-based mental health * Personal experience with self-injurious thoughts and behaviors (SITB) * English speaking * Willing and able to provide informed assent Child Exclusion Criteria: * Less than 12 or greater than 17 years of age (0-11 or 18 and over) * Do not self-identify as a sexual or gender minority (SGM) * Not involved in the juvenile justice, child welfare, and/or community-based mental health systems * No personal experience with self-injurious thoughts and behaviors (SITB) * Not English speaking * Unwilling and/or unable to provide informed assent Caregiver Inclusion Criteria: * 18-80 years of age * Primary Caregiver of youth who meet child inclusion criteria listed above * English speaking * Willing and able to provide informed consent Caregiver Exclusion Criteria: * Less than 18 or greater than 80 years of age (0-17 or 81 and over) * Not the Primary Caregiver of youth who meet child inclusion criteria listed above * Not English speaking * Unwilling and/or unable to provide informed consent

Contact & Investigator

Central Contact

Dana M. Prince, PhD

✉ dana.prince@case.edu

📞 216-368-1707

Principal Investigator

Dana M. Prince, PhD

PRINCIPAL INVESTIGATOR

Case Western Reserve University

Frequently Asked Questions

Who can join the NCT07214233 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 17 Years, studying Suicide. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07214233 currently recruiting?

Yes, NCT07214233 is actively recruiting participants. Contact the research team at dana.prince@case.edu for enrollment information.

Where is the NCT07214233 trial being conducted?

This trial is being conducted at Cleveland, United States.

Who is sponsoring the NCT07214233 clinical trial?

NCT07214233 is sponsored by Case Western Reserve University. The principal investigator is Dana M. Prince, PhD at Case Western Reserve University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology